Heather Amrine‐Madsen

Author

GlaxoSmithKline (United States)

Also Known As

H Amrine-Madsen, H. Amrine-Madsen, Heather Amrine-Madsen, Heather Amrine‐Madsen, Heather M. Amrine-Madsen

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)Research Triangle Park Foundation South College GlaxoSmithKline (United Kingdom)University of California, Riverside

About

Heather Amrine‐Madsen is an author at GlaxoSmithKline (United States) specializing in medicine, drug resistance, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	889
2	Health Sciences	9	9	457
3	Natural Sciences	1	1	119
4	Public Health	1	1	40
5	Biochemistry	1	1	144

Heather Amrine‐Madsen

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease Allen D. Roses, Michael W. Lutz, Heather Amrine‐Madsen, The Pharmacogenomics Journal	2009	388
A new phylogenetic marker, apolipoprotein B, provides compelling evidence for eutherian relationships Heather Amrine‐Madsen, Klaus‐Peter Koepfli, Robert K. Wayne, Molecular Phylogenetics and Evolution	2003	197
Incidence and cost of hospitalizations associated with Staphylococcus aureusskin and soft tissue infections in the United States from 2001 through 2009 Jose A. Suaya, Robertino M. Mera, Adrian Cassidy, BMC Infectious Diseases	2014	152
Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in <i>Staphylococcus aureus</i> Jianzhong Huang, Paul W. O’Toole, Wei Shen, Antimicrobial Agents and Chemotherapy Molecular BiologyEscherichia ColiAntibiotic ResistanceBacterial PathogensDrug Resistance	2004	144
Nuclear gene sequences provide evidence for the monophyly of australidelphian marsupials Heather Amrine‐Madsen, Mark Scally, Michael Westerman, Molecular Phylogenetics and Evolution Morphological EvidenceNuclear Gene SequencesPhylogeneticsNatural SciencesGenetics	2003	119
Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible <i>Staphylococcus aureus</i> Isolates from Global Clinical Trials Richard V. Goering, Ribhi M. Shawar, Nicole Scangarella, Journal of Clinical Microbiology	2008	114
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption Justin Harper, Shari N. Gordon, Chi Ngai Chan, Nature Medicine Human RetrovirusImmunologyAntiviral TherapyAntiviral ResponseAntiviral Drug	2020	101
Increasing Role of <i>Staphylococcus aureus</i> and Community-Acquired Methicillin-Resistant <i>Staphylococcus aureus</i> Infections in the United States: A 10-Year Trend of Replacement and Expansion Robertino M. Mera, Jose A. Suaya, Heather Amrine‐Madsen, Microbial Drug Resistance	2011	98
The role of positive selection in determining the molecular cause of species differences in disease Jessica Vamathevan, Samiul Hasan, Richard D. Emes, BMC Evolutionary Biology	2008	90
<i>Acinetobacter baumannii</i> 2002–2008: Increase of Carbapenem-Associated Multiclass Resistance in the United States Robertino M. Mera, Linda A. Miller, Heather Amrine‐Madsen, Microbial Drug Resistance Surveillance NetworkAntibiotic ResistanceBacterial PathogensUnited StatesDrug Resistance	2010	81

Page 1